Pure Global

Smart Watch Insights to Prevent Exacerbations and Recurrence - Health Study: SWIPER-HEALTH - Trial NCT06011395

Access comprehensive clinical trial information for NCT06011395 through Pure Global AI's free database. This phase not specified trial is sponsored by Imperial College London and is currently Enrolling by invitation. The study focuses on Cardiovascular Diseases. Target enrollment is 1800 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06011395
Enrolling by invitation
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06011395
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Smart Watch Insights to Prevent Exacerbations and Recurrence - Health Study: SWIPER-HEALTH

Study Focus

Cardiovascular Diseases

Smartwatch

Observational

device

Sponsor & Location

Imperial College London

London, United Kingdom

Timeline & Enrollment

N/A

Aug 30, 2023

Aug 30, 2025

1800 participants

Primary Outcome

Uptake of cardiac rehabilitation

Summary

Aims of the study:
 
 - To measure the rate of completion of a digital cardiac rehabilitation programme at
 Imperial College Healthcare NHS Trust (ICHNT)
 
 - To measure the health economic impact of a digital cardiac rehabilitation programme at
 ICHNT
 
 Any adult patient eligible for ICHNT cardiac rehabilitation (CR) programmes is eligible to
 participate. Participants will receive a commercially available smart watch and be asked to
 wear the device as much as possible. In addition, they will be asked to download a smartphone
 application called 'Imperial Healthy Hearts', which displays movement and information on
 heart rate, breathing and oxygen levels to both the participant and the research team
 (digital data). The Healthy Hearts app also allows the direct care team to provide
 educational materials to patients as part of their routine care.
 
 The clinical content and structure of the CR programme is determined by the clinical CR team,
 and does not deviate from established local and national standards and practices.
 
 Researchers will capture physiological data such as heart rate, respiratory rate, blood
 pressure (where available) and oxygen saturation (where available) via the Healthy Hearts
 platform. Researchers will also capture clinical information from the electronic health
 record, and will compare CR programme uptake and completion rates with historical data and
 national targets.

ICD-10 Classifications

Cardiovascular disease, unspecified
Hypertensive heart disease
Other ill-defined heart diseases
Heart disease, unspecified
Observation for other suspected cardiovascular diseases

Data Source

ClinicalTrials.gov

NCT06011395

Device Trial